Form 4: Thermo Fisher Scientific Executive Acquires Shares and Stock Options

Joseph R. Holmes, VP & Chief Accounting Officer of Thermo Fisher Scientific, reports acquisition of common stock and stock options.

Summary

• On February 19, 2025, Joseph R. Holmes, VP & Chief Accounting Officer of Thermo Fisher Scientific, acquired 157 shares of common stock through the Issuer's employees' stock purchase plan.
• He also acquired 474 shares of common stock related to a performance-based restricted stock unit award granted on February 21, 2024, where the performance criteria were satisfied.
• Additionally, Holmes acquired options to buy 959 shares of common stock at a price of $530.86.
• Following these transactions, Holmes beneficially owns 1,957.9605 shares of common stock directly and 959 stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The transactions reflect standard executive compensation practices and achievement of performance goals, indicating a healthy company performance.

Positives

• The acquisition of shares through the employee stock purchase plan demonstrates confidence in the company's future.
• The vesting of performance-based restricted stock units indicates that performance targets were achieved, which is a positive sign for the company's performance.
• The acquisition of stock options provides an incentive for the executive to further contribute to the company's success.

Future Outlook

The performance-based restricted stock units are subject to adjustment based on the company's total shareholder return CAGR compared to its peer group through December 31, 2026.

Industry Context

Executive stock ownership is common in publicly traded companies like Thermo Fisher Scientific to align management's interests with those of shareholders.

Comparison to Industry Standards

• Thermo Fisher Scientific's executive compensation practices, including stock options and restricted stock units, are generally in line with those of its peers in the life sciences and diagnostics industries, such as Danaher, Agilent Technologies, and Illumina.
• These companies often use a mix of salary, bonus, and equity-based compensation to attract and retain top talent.
• Performance-based equity awards, like the restricted stock units granted to Holmes, are a common way to incentivize executives to achieve specific financial or strategic goals.

Stakeholder Impact

• The transactions signal to shareholders that the executive's interests are aligned with theirs.
• Employees may be motivated by the company's performance and the availability of stock purchase plans.
• The vesting of performance-based awards suggests that the company is meeting its goals, which can positively impact customers and suppliers.

Next Steps

• The stock options will vest in four equal annual installments beginning on February 28, 2026.
• The remaining one-third of the performance-based restricted stock units will vest on February 28, 2027, subject to adjustment based on long-term performance.

Key Dates

Keywords

Thermo Fisher Scientific, insider trading, Form 4, stock options, common stock, Joseph R. Holmes, executive compensation, stock purchase plan, performance-based restricted stock units